Open in Screener

LFWD

Lifeward Ltd

Aug 08 • 04:00PM ET

0.6696

Dollar change -0.0103
Percentage change -1.51	%

Healthcare • Medical Devices • USA • NASD

Peers: ISRG GMED PODD CUTR ARAY HAE IART BIO MASI STXS

Index	-	P/E	-	EPS (ttm)	-3.05	Insider Own	3.29%	Shs Outstand	15.60M	Perf Week	-3.85%
Market Cap	10.45M	Forward P/E	-	EPS next Y	-0.42	Insider Trans	-0.37%	Shs Float	15.09M	Perf Month	-10.78%
Enterprise Value	5.15M	PEG	-	EPS next Q	-0.28	Inst Own	1.80%	Short Float	10.65%	Perf Quarter	-51.12%
Income	-27.50M	P/S	0.41	EPS this Y	68.77%	Inst Trans	-83.56%	Short Ratio	2.30	Perf Half Y	-50.22%
Sales	25.41M	P/B	0.39	EPS next Y	59.62%	ROA	-65.46%	Short Interest	1.61M	Perf YTD	-61.29%
Book/sh	1.74	P/C	1.77	EPS next 5Y	-	ROE	-93.11%	52W High	4.29 -84.39%	Perf Year	-82.24%
Cash/sh	0.38	P/FCF	-	EPS past 3/5Y	-21.43% 29.33%	ROIC	-148.62%	52W Low	0.50 33.65%	Perf 3Y	-90.35%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	62.63% 39.41%	Gross Margin	31.25%	Volatility	5.05% 7.54%	Perf 5Y	-92.53%
Dividend TTM	-	EV/Sales	0.20	EPS Y/Y TTM	-8.25%	Oper. Margin	-70.45%	ATR (14)	0.06	Perf 10Y	-99.96%
Dividend Ex-Date	-	Quick Ratio	1.43	Sales Y/Y TTM	41.92%	Profit Margin	-108.21%	RSI (14)	35.07	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	2.18	EPS Q/Q	36.90%	SMA20	-9.13%	Beta	0.17	Target Price	6.50
Payout	-	Debt/Eq	0.03	Sales Q/Q	-4.71%	SMA50	-23.17%	Rel Volume	0.25	Prev Close	0.68
Employees	80	LT Debt/Eq	0.00	Earnings	Aug 14 BMO	SMA200	-55.74%	Avg Volume	699.84K	Price	0.67
IPO	Sep 12, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	-33.33% -13.80%	Trades		Volume	175,978	Change	-1.51%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-10-25	Initiated	Laidlaw	Buy	$10
Apr-03-17	Downgrade	Barclays	Equal Weight → Underweight	$2.50 → $1.50
Dec-16-16	Initiated	Oppenheimer	Outperform
Jul-15-16	Initiated	Piper Jaffray	Overweight	$10
May-22-15	Upgrade	Canaccord Genuity	Hold → Buy	$11 → $17
May-08-15	Reiterated	Barclays	Equal Weight	$20 → $13
Oct-07-14	Initiated	Barclays	Equal Weight	$28

Aug-07-25 05:30PM	Lifeward to Report Second Quarter Financial Results on August 14, 2025 (GlobeNewswire)
05:25PM	Turtle Beach (TBCH) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
Aug-06-25 10:50AM	Verb Technology Company, Inc. (VERB) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
Aug-05-25 06:20PM	8x8 (EGHT) Q1 Earnings Match Estimates (Zacks)
Aug-04-25 08:30AM	Lifeward Expands Distribution Partnership with SportsMed Ltd. to Add Coverage for United Arab Emirates and Entire Gulf Cooperation Council Region (GlobeNewswire)
11:00AM	Loading…
Jul-07-25 11:00AM	MedRhythms Appoints Larry Jasinski as Chief Executive Officer to Lead Next Phase of Growth and Commercial Expansion (PR Newswire)
Jun-26-25 04:15PM	Lifeward Announces Closing of $2.6 Million Public Offering (GlobeNewswire) +15.16%
09:15AM	Lifeward prices 4M shares at 65c in public offering (TipRanks)
Jun-25-25 09:10AM	Lifeward Announces Pricing of $2.6 Million Public O?ering (GlobeNewswire) -36.80%
Jun-24-25 04:05PM	Administrative Law Judge Determines ReWalk Personal Exoskeleton is "Reasonable and Necessary" for Medicare Beneficiary (GlobeNewswire)
May-20-25 08:00AM	Sidoti Events, LLC's Virtual May Micro-Cap Conference (ACCESSWIRE)
May-19-25 08:30AM	Lifeward Names Mark Grant as New CEO (GlobeNewswire)
06:00AM	Lifeward to Present at Sidoti Virtual Investor Conference on May 21 (GlobeNewswire)
May-16-25 03:08AM	Lifeward Ltd (LFWD) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com)
May-15-25 09:15AM	Lifeward (LFWD) Reports Q1 Loss, Lags Revenue Estimates (Zacks) -10.42%
08:00AM	Loading…
08:00AM	Lifeward Ltd. Reports First Quarter 2025 Financial Results (GlobeNewswire)
May-08-25 08:30AM	Lifeward Completes Research Program with Israeli Human-Robot Interaction Consortium to Integrate Artificial Intelligence and Exoskeletons (GlobeNewswire)
May-07-25 04:30PM	Lifeward to Report First Quarter 2025 Financial Results on May 15, 2025 (GlobeNewswire)
Apr-29-25 08:30AM	First Major U.S. Commercial Health Insurer Approves Purchase of ReWalk 7 Personal Exoskeleton (GlobeNewswire)
Apr-24-25 08:30AM	Paralyzed Israeli Soldier Walks Again with Use of the ReWalk Personal Exoskeleton (GlobeNewswire)
Apr-16-25 07:13AM	LFWD Stock Falls Despite Launch of Next-Generation Mobility ReWalk 7 (Zacks)
Apr-15-25 08:15AM	Lifeward Launches Sales of the ReWalk 7 Personal Exoskeleton in U.S. Market (GlobeNewswire)
Mar-23-25 08:40AM	Lifeward Ltd. (LFWD): Among the Penny Stocks With Huge Upside Potential According to Analysts (InsiderMonkey)
Mar-13-25 09:15AM	FDA Issues Clearance for ReWalk 7 Exoskeleton (GlobeNewswire) +8.84%
Mar-08-25 02:03AM	Lifeward Ltd (LFWD) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic Growth ... (GuruFocus.com)
Mar-07-25 08:00AM	Lifeward Ltd. Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Mar-06-25 08:00AM	Lifeward and CorLife Finalize Partnership to Expand Workers' Compensation Access to ReWalk Exoskeleton (GlobeNewswire) -8.14%
Mar-05-25 08:00AM	Lifeward and MYOLYN Expand Partnership to Enhance Patient Access to MyoCycle FES Cycling Therapy System for Home Use (GlobeNewswire)
Feb-28-25 08:00AM	Lifeward to Report Fourth Quarter and Fiscal Year-End 2024 Financial Results on March 7, 2025 (GlobeNewswire)
Feb-19-25 09:10AM	Lifeward Announces CEO Transition (GlobeNewswire) -8.00%
08:20AM	Loading…
Feb-06-25 08:20AM	Lifeward finalizes agreement with BARMER (TipRanks)
Feb-05-25 08:00AM	Lifeward Finalizes Personal Exoskeleton Reimbursement Agreement with BARMER, Adding 8.5 Million Covered Lives in Germany (GlobeNewswire)
Feb-04-25 08:00AM	Lifeward to Host Virtual Investor Event to Discuss Commercial Strategy, Key Initiatives, and Financial Outlook on February 20, 2025 (GlobeNewswire)
Jan-13-25 08:30AM	Lifeward CEO Issues Year-End 2024 Open Letter to Shareholders and Provides 2025 Commercial and Operational Priorities (GlobeNewswire) -17.68%
07:45AM	Lifeward Cancels Its Extraordinary General Meeting of Shareholders (GlobeNewswire)
Jan-08-25 04:15PM	Lifeward Announces Closing of $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (GlobeNewswire) -10.41%
Jan-07-25 08:05AM	Lifeward Announces $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (GlobeNewswire) -27.30%
Dec-27-24 05:49PM	Lifeward Announces Postponement of its Extraordinary General Meeting of Shareholders (GlobeNewswire) +18.24% -7.46%
Nov-19-24 08:30AM	Coverage for ReWalk Personal Exoskeleton Expands as Hungary Joins the U.S. and Germany with a Policy Providing Access to Exoskeletons (GlobeNewswire) +5.14%
Nov-13-24 02:08AM	Lifeward Ltd (LFWD) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Operational ... (GuruFocus.com) -16.32%
Nov-12-24 08:00AM	Lifeward Ltd. Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Nov-07-24 04:05PM	Lifeward Announces Appointment of Robert J. Marshall to Its Board of Directors (GlobeNewswire)
Nov-05-24 04:38PM	Lifeward to Report Third Quarter Financial Results on November 12, 2024 (GlobeNewswire) -7.24%
Nov-04-24 08:00AM	Lifeward Streamlines U.S. Operations in Next Phase of Growth and Operational Efficiencies (GlobeNewswire)
Oct-24-24 04:30PM	Lifeward Ltd. to Present at ThinkEquity Conference on Oct 30, 2024 (GlobeNewswire)
Sep-24-24 05:00PM	Lifeward Launches Direct Sales of AlterG Product Line in Germany (GlobeNewswire)
Sep-12-24 08:30AM	ReWalk Robotics Ltd. Finalizes Corporate Name Change to Lifeward Ltd. (GlobeNewswire)
Sep-10-24 08:30AM	Lifeward Announces Appointment of Dr. Keith E. Tansey as Consulting Director of Clinical Research (GlobeNewswire)
Sep-05-24 08:30AM	Lifeward's First Annual Step Challenge Donates 5,000 to German Association for People Living with Spinal Cord Injury (GlobeNewswire)
Sep-04-24 04:15PM	Lifeward to Present at the H.C. Wainwright 26th Annual Global Investment Conference (GlobeNewswire)
Aug-15-24 08:00AM	Lifeward Reports Second Quarter 2024 Financial Results (GlobeNewswire) +30.66%
Aug-08-24 04:15PM	Lifeward to Report Second Quarter Financial Results on August 15, 2024 (GlobeNewswire) -6.52%
Jul-02-24 04:30PM	Lifeward Announces Appointment of Joseph E. Turk as Incoming Chairman of its Board of Directors (GlobeNewswire)
Jun-26-24 08:30AM	Lifeward Unveils Newest Addition to Its AlterG Anti-Gravity Product Line Introducing AlterG NEO (GlobeNewswire)
Jun-11-24 10:50AM	Sidoti Events, LLC's Virtual June Small-Cap Conference (ACCESSWIRE)
Jun-04-24 04:30PM	Lifeward to Present at Sidoti Virtual Investor Conference on June 12 (GlobeNewswire)
May-28-24 03:32AM	LFWD Stock Earnings: Rewalk Robotics Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace)
May-16-24 08:18AM	ReWalk Robotics Ltd. (NASDAQ:LFWD) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-15-24 09:10AM	ReWalk Robotics (LFWD) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
08:00AM	Lifeward Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-14-24 12:00PM	ReWalk (LFWD) Upgraded to Strong Buy: Here's What You Should Know (Zacks)
May-07-24 04:30PM	Lifeward to Report First Quarter Financial Results on May 15, 2024 (GlobeNewswire) +7.47%
May-02-24 10:01AM	Earnings Preview: ReWalk Robotics (LFWD) Q1 Earnings Expected to Decline (Zacks)
Apr-26-24 10:19AM	Should Lifeward (LFWD) be in Your Portfolio Ahead of Q1 Earnings? (Zacks)
Apr-23-24 09:55AM	Bears are Losing Control Over ReWalk (LFWD), Here's Why It's a 'Buy' Now (Zacks)
Apr-19-24 08:30AM	Lifeward Announces the Appointment of Mike Swinford to its Board of Directors (GlobeNewswire)
Apr-12-24 08:30AM	Medicare Revises 2024 Fee Schedule to Include Payment Rate for the ReWalk Personal Exoskeleton (GlobeNewswire)
Apr-01-24 04:30PM	Lifeward CEO Issues Open Letter to Shareholders on Progress to Finalize Exoskeleton Medicare Payment Rate (GlobeNewswire)
Mar-24-24 03:54PM	12 Best Biotech Penny Stocks to Invest In (Insider Monkey)
Mar-22-24 08:30AM	VA STAND Act introduced in the United States Senate (GlobeNewswire) +12.29%
Mar-13-24 11:45AM	Lifeward Announces Reverse Share Split (GlobeNewswire) -12.50%
Mar-08-24 08:30AM	ReStore Exo-Suit Publications Demonstrate Improved Walking Outcomes Versus Conventional Stroke Therapy (GlobeNewswire)
Mar-01-24 12:00PM	All You Need to Know About ReWalk (LFWD) Rating Upgrade to Strong Buy (Zacks)
08:45AM	Lifeward announces the Centers for Medicare & Medicaid Services ( CMS ) is deferring its final decision on the payment rate for personal exoskeletons so that more recent claims information on the current, more advanced ReWalk Personal Exoskeleton may be considered (GlobeNewswire)
Feb-27-24 09:15AM	ReWalk Robotics (LFWD) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
08:00AM	Lifeward Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Feb-20-24 08:30AM	Lifeward to Report Fourth Quarter and Fiscal Year-End 2023 Financial Results on February 27, 2024 (GlobeNewswire)
Jan-29-24 08:00AM	ReWalk Robotics Transforms Company Identity, Rebrands as Lifeward (GlobeNewswire) +6.07%
Jan-28-24 08:07PM	7 AgeTech Stocks to Profit From the Booming Longevity Market (InvestorPlace)
Jan-16-24 08:47AM	Sidoti Events, LLC's Virtual January Micro-Cap Conference (ACCESSWIRE)
Jan-12-24 08:30AM	ReWalk Robotics Expands Direct Sales Coverage to Canada (GlobeNewswire)
Jan-11-24 05:00PM	ReWalk Robotics Ltd. to Present at Sidoti Virtual Investor Conference on January 17 (GlobeNewswire)
Jan-05-24 08:00AM	First ReWalk Personal Exoskeleton Claim Paid by Medicare (GlobeNewswire) +21.57%
Jan-04-24 08:00AM	ReWalk Robotics CEO Issues Year-End 2023 Open Letter to Shareholders and Provides 2024 Commercial and Operational Priorities (GlobeNewswire)
Nov-30-23 04:45PM	ReWalk Robotics Presents on Personal Exoskeleton Pricing at Medicare Public Meeting (GlobeNewswire) +5.38% -5.24%
Nov-28-23 07:33PM	Penny Stock Powerhouses: 7 Picks Poised for Explosive Growth (InvestorPlace)
08:00AM	ReWalk Robotics Demonstrates AI Autonomous Decision Making in Next Generation Exoskeleton Prototype (GlobeNewswire)
Nov-20-23 09:20AM	7 Cheap Stocks to Buy Now if You Have $100 to Spend: November Edition (InvestorPlace)
Nov-14-23 08:15AM	ReWalk: Q3 Earnings Snapshot (Associated Press Finance)
08:06AM	ReWalk Robotics Reports Third Quarter 2023 Financial Results (GlobeNewswire)
Nov-10-23 08:30AM	New Bill Facilitates Veteran Access to Powered Exoskeletons (GlobeNewswire)
Nov-07-23 08:00AM	ReWalk Robotics to Discuss Medicare's Preliminary Payment Determination for ReWalk Personal Exoskeleton (GlobeNewswire)
07:40AM	ReWalk Robotics to Report Third Quarter 2023 Financial Results on November 14, 2023 (GlobeNewswire)
Nov-06-23 08:00AM	In Historic Move, Medicare Proposes Preliminary Reimbursement Level for ReWalk Personal Exoskeleton (GlobeNewswire)
Nov-02-23 08:00AM	Medicare Coverage Solidified for ReWalk Personal Exoskeleton (GlobeNewswire)
Oct-31-23 09:25AM	The 3 Best Penny Stocks to Buy in November (InvestorPlace) +9.16%
Oct-18-23 08:30AM	ReWalk Robotics Exhibits at the GITEX GLOBAL Intelligent Connectivity / AI Pavilion (GlobeNewswire)
Sep-20-23 08:00AM	ReWalk Robotics Offers Thanks to Former Director for His Loyal Service and Valuable Contributions (GlobeNewswire)
Sep-06-23 08:00AM	ReWalk Robotics Ltd. to Present Virtually at H.C. Wainwright 25th Annual Global Investment Conference (GlobeNewswire)
Sep-05-23 08:30AM	ReWalk Robotics Announces Additional Change to Board of Directors (GlobeNewswire)

Lifeward Ltd. is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The firm's exoskeletons provide hip and knee motion to enable individuals with spinal cord injury (SCI) to stand upright, walk, turn, and climb and descend stairs. Its products include ReWalk Exo-Suit and ReWalk Personal 6.0. The company was founded by Amit Goffer on June 20, 2001 and is headquartered in Marlborough, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Jasinski Lawrence J	Chief Executive Officer	May 21 '25	Sale	1.26	1,909	2,405	98,728	May 22 04:29 PM
Lind Global Fund II LP	10% Owner	Jan 06 '25	Sale	3.36	381,676	1,283,102	1,049,430	Jan 08 05:20 PM
Lind Global Fund II LP	10% Owner	Jan 07 '25	Sale	1.94	191,434	371,907	857,996	Jan 08 05:20 PM
Richner Randel	Director	Dec 13 '24	Sale	1.68	4,285	7,214	0	Dec 17 04:08 PM
Turk Joseph E Jr	Director	Dec 13 '24	Buy	1.69	6,000	10,140	18,516	Dec 17 08:55 AM
Swinford Michael	Director	Nov 25 '24	Buy	2.03	21,622	43,858	65,040	Nov 27 08:03 AM
Swinford Michael	Director	Nov 22 '24	Buy	1.83	16,907	30,899	43,418	Nov 26 07:07 AM
Swinford Michael	Director	Nov 20 '24	Buy	1.84	16,471	30,231	26,511	Nov 25 06:16 AM
Jasinski Lawrence J	Chief Executive Officer	Sep 13 '24	Sale	3.26	2,672	8,700	100,637	Sep 16 05:34 PM
Jasinski Lawrence J	Officer	Sep 13 '24	Proposed Sale	3.27	2,672	8,737		Sep 16 06:46 AM
Lynch Jeannine	VP of Market Access & Strategy	Sep 03 '24	Sale	3.30	1,625	5,358	47,658	Sep 04 07:37 PM

Dollar change -1.98
Percentage change -2.10	%

LMAT Lemaitre Vascular Inc daily Stock Chart

Peers: ABT ISRG JNJ BSX EW MDT SYK COO HOLX XRAY

| Held by: IJR VTI SDVY IWM VXF IWO IJT SPSM IHI SLYG

Index	RUT	P/E	44.82	EPS (ttm)	2.06	Insider Own	8.59%	Shs Outstand	22.64M	Perf Week	13.87%
Market Cap	2.09B	Forward P/E	37.13	EPS next Y	2.49	Insider Trans	-9.89%	Shs Float	20.69M	Perf Month	7.62%
Enterprise Value	1.96B	PEG	3.31	EPS next Q	0.57	Inst Own	93.71%	Short Float	6.65%	Perf Quarter	13.23%
Income	47.12M	P/S	8.90	EPS this Y	18.27%	Inst Trans	1.13%	Short Ratio	8.65	Perf Half Y	-7.56%
Sales	234.64M	P/B	5.76	EPS next Y	8.87%	ROA	10.02%	Short Interest	1.38M	Perf YTD	0.15%
Book/sh	16.02	P/C	6.54	EPS next 5Y	13.55%	ROE	13.81%	52W High	109.58 -15.79%	Perf Year	12.69%
Cash/sh	14.11	P/FCF	39.93	EPS past 3/5Y	15.55% 16.99%	ROIC	8.63%	52W Low	71.42 29.21%	Perf 3Y	71.68%
Dividend Est.	0.80 (0.87%)	EV/EBITDA	30.14	Sales past 3/5Y	12.50% 13.40%	Gross Margin	67.27%	Volatility	4.16% 2.85%	Perf 5Y	205.77%
Dividend TTM	0.72 (0.78%)	EV/Sales	8.33	EPS Y/Y TTM	23.98%	Oper. Margin	23.37%	ATR (14)	2.88	Perf 10Y	548.03%
Dividend Ex-Date	Aug 21, 2025	Quick Ratio	11.74	Sales Y/Y TTM	14.11%	Profit Margin	20.08%	RSI (14)	69.20	Recom	1.91
Dividend Gr. 3/5Y	13.30% 13.49%	Current Ratio	13.60	EPS Q/Q	15.66%	SMA20	10.17%	Beta	0.76	Target Price	104.78
Payout	33.10%	Debt/Eq	0.51	Sales Q/Q	15.01%	SMA50	10.79%	Rel Volume	0.94	Prev Close	94.26
Employees	664	LT Debt/Eq	0.50	Earnings	Aug 05 AMC	SMA200	2.57%	Avg Volume	159.05K	Price	92.28
IPO	Oct 19, 2006	Option/Short	Yes / Yes	EPS/Sales Surpr.	5.88% 1.06%	Trades		Volume	149,596	Change	-2.10%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-06-25	Upgrade	Barrington Research	Mkt Perform → Outperform	$95
Feb-28-25	Downgrade	Oppenheimer	Outperform → Perform
Feb-28-25	Downgrade	Barrington Research	Outperform → Mkt Perform
Feb-13-25	Initiated	Wells Fargo	Equal Weight	$95
Oct-15-24	Initiated	Cantor Fitzgerald	Neutral	$96
Aug-02-24	Resumed	Lake Street	Buy	$85 → $105
May-31-24	Resumed	ROTH MKM	Buy	$100
Apr-26-24	Upgrade	Stifel	Hold → Buy	$59 → $75
Feb-06-24	Resumed	KeyBanc Capital Markets	Sector Weight
Oct-23-23	Initiated	JMP Securities	Mkt Outperform	$60
Sep-06-23	Initiated	Oppenheimer	Outperform	$70
Aug-03-23	Downgrade	Jefferies	Buy → Hold	$63 → $67
May-03-23	Upgrade	Barrington Research	Mkt Perform → Outperform	$62
Oct-28-22	Downgrade	Barrington Research	Outperform → Mkt Perform
Sep-16-21	Initiated	Jefferies	Buy	$70
Feb-12-21	Initiated	KeyBanc Capital Markets	Sector Weight
Mar-16-20	Upgrade	Sidoti	Neutral → Buy
Oct-24-19	Upgrade	Lake Street	Hold → Buy	$40
Oct-24-19	Downgrade	First Analysis Sec	Strong Buy → Outperform	$37 → $40
Oct-14-19	Upgrade	First Analysis Sec	Outperform → Strong Buy	$37

Show Previous Ratings

Aug-06-25 01:20PM	Why LeMaitre (LMAT) Stock Is Trading Up Today (StockStory) +8.91%
03:33AM	LeMaitre Vascular Inc (LMAT) Q2 2025 Earnings Call Highlights: Strong Sales Growth and ... (GuruFocus.com)
Aug-05-25 06:15PM	LeMaitre Vascular (LMAT) Beats Q2 Earnings and Revenue Estimates (Zacks)
06:10PM	LeMaitre (NASDAQ:LMAT) Exceeds Q2 Expectations, Full-Year Sales Guidance is Optimistic (StockStory)
05:11PM	LeMaitre: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Loading…
04:05PM	LeMaitre Q2 2025 Financial Results (GlobeNewswire)
Aug-04-25 11:40AM	PAHC vs. LMAT: Which Stock Should Value Investors Buy Now? (Zacks)
09:37AM	LeMaitre Vascular Inc (LMAT) Q2 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Aug-03-25 11:17PM	LeMaitre (LMAT) Reports Q2: Everything You Need To Know Ahead Of Earnings (StockStory)
Jul-17-25 12:09AM	2 Reasons to Avoid LMAT and 1 Stock to Buy Instead (StockStory)
Jul-08-25 04:04PM	LeMaitre Will Announce Second Quarter 2025 Earnings Results August 5, 2025 (GlobeNewswire)
Jun-26-25 04:19AM	5 Must-Read Analyst Questions From LeMaitre's Q1 Earnings Call (StockStory)
Jun-16-25 12:37AM	1 Small-Cap Stock with Exciting Potential and 2 to Keep Off Your Radar (StockStory)
Jun-09-25 10:52PM	Anteris Appoints David Roberts and Gregory Moss to its Board of Directors (GlobeNewswire)
May-16-25 06:35AM	LMAT Q1 Earnings Call: Sales Growth Outpaces Expectations, Margin Pressures Addressed (StockStory)
12:34AM	Loading…
May-09-25 12:34AM	1 Cash-Heavy Stock That Stand Out and 2 to Question (StockStory)
May-05-25 04:39PM	LeMaitre to Present at the Bank of America Securities 2025 Healthcare Conference (GlobeNewswire)
May-01-25 11:17PM	LeMaitre Vascular, Inc. (LMAT) Q1 2025 Earnings Call Transcript (Seeking Alpha) -12.79%
05:20PM	LeMaitre Vascular (LMAT) Lags Q1 Earnings Estimates (Zacks)
04:26PM	LeMaitre: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	LeMaitre Q1 2025 Financial Results (GlobeNewswire)
Apr-28-25 09:08AM	1 Profitable Stock with Impressive Fundamentals and 2 to Steer Clear Of (StockStory)
Apr-23-25 06:12PM	Cramer on LeMaitre Vascular (LMAT): "A Great Under-the-Radar Medical Device Stock" (Insider Monkey)
Apr-22-25 11:30AM	BD Stock Down Despite Monitoring Platform Launch to Boost Patient Care (Zacks)
Apr-21-25 08:57AM	FitLife Brands (FTLF) Surges 13.1%: Is This an Indication of Further Gains? (Zacks)
06:30AM	The Elephant In The Room - March Dividend Income Report (Seeking Alpha)
Apr-17-25 05:03AM	Q4 Earnings Highlights: LeMaitre (NASDAQ:LMAT) Vs The Rest Of The Surgical Equipment & Consumables - Specialty Stocks (StockStory)
Apr-14-25 09:48AM	BAX Stock Declines Despite Latest Product Launch Boosting Patient Care (Zacks)
Apr-10-25 11:37AM	LeMaitre (LMAT) Soars 7.7%: Is Further Upside Left in the Stock? (Zacks)
Apr-07-25 03:56PM	LeMaitre Will Announce First Quarter 2025 Earnings Results May 1, 2025 (GlobeNewswire)
08:27AM	Loading…
Apr-04-25 08:27AM	4 Low-Beta Healthcare Stocks to Beat Trump's Tariff Blues (Zacks)
07:47AM	Small-Cap Dividend Stocks: Hidden Gems Or High-Risk Plays? - Top U.S. And Canadian Ones (Seeking Alpha)
Apr-01-25 03:20PM	LeMaitre to Present at the 24th Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-31-25 05:13AM	2 Reasons to Avoid LMAT and 1 Stock to Buy Instead (StockStory)
Mar-29-25 10:30AM	Stocks Falling On Earnings - What To Do? February Dividend Income Report (Seeking Alpha)
Mar-25-25 12:45PM	3 Reasons Growth Investors Will Love LeMaitre (LMAT) (Zacks)
Mar-22-25 12:31AM	Dividend Champion, Contender, And Challenger Highlights: Week Of March 23 (SeekingAlpha)
Mar-20-25 09:05AM	Invesco Health Care Fund Q4 2024 Commentary (SeekingAlpha)
09:00AM	Precision Optics Appoints Joseph P. Pellegrino, Jr. to Board of Directors (GlobeNewswire)
Mar-13-25 09:35AM	Down -15.37% in 4 Weeks, Here's Why LeMaitre (LMAT) Looks Ripe for a Turnaround (Zacks)
Mar-03-25 05:06PM	LeMaitre to Participate at Upcoming Investor Conferences in March (GlobeNewswire)
12:00PM	LeMaitre (LMAT) Upgraded to Buy: Here's What You Should Know (Zacks)
Feb-28-25 02:40AM	LeMaitre Vascular Inc (LMAT) Q4 2024 Earnings Call Highlights: Strong Sales Growth and ... (GuruFocus.com) -8.07%
Feb-27-25 06:45PM	LeMaitre Vascular (LMAT) Meets Q4 Earnings Estimates (Zacks)
05:47PM	LeMaitre: Q4 Earnings Snapshot (Associated Press Finance)
04:32PM	LeMaitre (NASDAQ:LMAT) Misses Q4 Sales Targets, Stock Drops 11% (StockStory)
04:05PM	LeMaitre Q4 2024 Financial Results (GlobeNewswire)
Feb-26-25 08:05AM	What To Expect From LeMaitres (LMAT) Q4 Earnings (StockStory)
07:33AM	Earnings To Watch: LeMaitre Vascular Inc (LMAT) Reports Q4 2024 Result (GuruFocus.com)
Feb-25-25 02:52PM	Medtronic Stock Gets IBD Rating Lift (Investor's Business Daily)
Jan-27-25 03:15PM	LeMaitre Will Announce Fourth Quarter 2024 Earnings Results February 27, 2025 (GlobeNewswire)
Dec-16-24 11:28PM	LeMaitre Vascular Prices $150 Million Convertible Senior Notes (GlobeNewswire) -8.53%
07:57AM	LeMaitre Vascular Announces Proposed Convertible Senior Notes Offering (GlobeNewswire)
Dec-11-24 02:59PM	Inari Medical Stock Gets RS Rating Upgrade (Investor's Business Daily)
Dec-03-24 02:51PM	Novocure Stock Earns 96 RS Rating (Investor's Business Daily)
Nov-25-24 05:20PM	LeMaitre to Participate at Upcoming Investor Conferences in December (GlobeNewswire)
Nov-01-24 04:47PM	LeMaitre to Participate at Upcoming Investor Conferences in November (GlobeNewswire) +7.34%
11:02AM	LeMaitre Vascular Inc (LMAT) Q3 2024 Earnings Call Highlights: Robust Sales Growth and ... (GuruFocus.com)
Oct-31-24 05:20PM	LeMaitre Vascular (LMAT) Surpasses Q3 Earnings and Revenue Estimates (Zacks)
04:15PM	LeMaitre: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	LeMaitre Q3 2024 Financial Results (GlobeNewswire)
Oct-15-24 04:34PM	LeMaitre Will Announce Third Quarter 2024 Earnings Results October 31, 2024 (GlobeNewswire)
Oct-09-24 03:52PM	LeMaitre Vascular Inc (LMAT) Q2 2024 Earnings Call Highlights: Strong Growth Across Key Metrics ... (GuruFocus.com)
Sep-23-24 12:00PM	All You Need to Know About LeMaitre (LMAT) Rating Upgrade to Strong Buy (Zacks)
Sep-16-24 12:28PM	LeMaitre Vascular (LMAT) Surged Due to Robust Global Markets (Insider Monkey)
Aug-27-24 04:54PM	LeMaitre to Participate at Upcoming Investor Conferences in September (GlobeNewswire)
Aug-16-24 01:47AM	Robust Quarterly Result Lifted LeMaitre Vascular (LMAT) in Q2 (Insider Monkey)
Aug-06-24 12:00PM	LeMaitre (LMAT) Upgraded to Strong Buy: Here's Why (Zacks)
Aug-01-24 05:55PM	LeMaitre Vascular (LMAT) Surpasses Q2 Earnings and Revenue Estimates (Zacks)
04:51PM	LeMaitre: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	LeMaitre Q2 2024 Financial Results (GlobeNewswire)
Jul-16-24 05:26PM	LeMaitre Will Announce Second Quarter 2024 Earnings Results August 1, 2024 (GlobeNewswire)
Jun-21-24 12:00PM	LeMaitre (LMAT) Upgraded to Strong Buy: Here's What You Should Know (Zacks)
May-21-24 05:16PM	LeMaitre to Present at the Jefferies Global Healthcare Conference (GlobeNewswire)
May-20-24 12:00PM	All You Need to Know About LeMaitre (LMAT) Rating Upgrade to Strong Buy (Zacks)
May-08-24 07:02PM	Insider Sale: President and Director David Roberts Sells Shares of LeMaitre Vascular Inc (LMAT) (GuruFocus.com)
05:21PM	Lemaitre Vascular Insider Sold Shares Worth $9,314,501, According to a Recent SEC Filing (MT Newswires)
May-03-24 11:28AM	LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q1 2024 Earnings Call Transcript (Insider Monkey) +11.16%
11:21AM	Barrington Boosts Price Target on LeMaitre Vascular to $79 From $69, Keeps Outperform Rating (MT Newswires)
May-02-24 09:55PM	LMAT Stock Earnings: LeMaitre Vascular Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
06:25PM	LeMaitre Vascular (LMAT) Q1 Earnings and Revenues Top Estimates (Zacks)
05:42PM	LeMaitre Vascular Inc (LMAT) Q1 2024 Earnings: Surpasses Analyst Revenue Forecasts (GuruFocus.com)
05:26PM	LeMaitre: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	LeMaitre Q1 2024 Financial Results (GlobeNewswire)
Apr-26-24 06:34AM	Stifel Upgrades LeMaitre Vascular to Buy From Hold, Adjusts Price Target to $75 From $59 (MT Newswires)
Apr-19-24 11:42AM	LeMaitre Will Announce First Quarter 2024 Earnings Results May 2, 2024 (GlobeNewswire)
Mar-26-24 04:52PM	LeMaitre to Present at the 23rd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-05-24 12:00PM	LeMaitre Vascular (LMAT) is a Great Momentum Stock: Should You Buy? (Zacks)
Mar-01-24 04:37PM	LeMaitre to Participate at Upcoming Investor Conferences in March (GlobeNewswire)
Feb-29-24 12:00PM	LeMaitre (LMAT) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Feb-28-24 12:08PM	Q4 2023 LeMaitre Vascular Inc Earnings Call (Thomson Reuters StreetEvents) +14.41%
09:39AM	LeMaitre Vascular, Inc. (NASDAQ:LMAT) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-27-24 05:43PM	LeMaitre: Q4 Earnings Snapshot (Associated Press Finance)
05:32PM	LeMaitre Vascular Inc (LMAT) Reports Robust Q4 2023 Results with Significant Sales and Net ... (GuruFocus.com)
04:05PM	LeMaitre Q4 2023 Financial Results (GlobeNewswire)
Feb-20-24 10:00AM	LeMaitre Vascular (LMAT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Feb-13-24 10:37AM	LeMaitre Will Announce Fourth Quarter 2023 Earnings Results February 27, 2024 (GlobeNewswire) -5.24%
Jan-11-24 02:31PM	LeMaitre to Present at the 26th Annual Needham Growth Conference (GlobeNewswire)
Dec-13-23 03:06AM	Insider Sell: Chairman and CEO George Lemaitre Sells 22,288 Shares of LeMaitre Vascular Inc (LMAT) (GuruFocus.com)
Dec-11-23 11:06PM	LeMaitre Vascular Inc's CEO George Lemaitre Sells Shares: An Insider Analysis (GuruFocus.com)

LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company focuses on the design, marketing, sales, service, and technical support of medical devices and implants for the treatment of peripheral vascular disease. Its products include balloon catheters, carotid shunts, biologic patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, vascular grafts, and powered phlebectomy. The company was founded by George D. LeMaitre on November 28, 1983 and is headquartered in Burlington, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
LeMaitre George W	Chairman and CEO	Aug 06 '25	Sale	93.51	100,000	9,350,530	1,727,003	Aug 08 05:48 PM
JOHN ADAM ROUSH	Director	Aug 08 '25	Proposed Sale	93.49	939	87,784		Aug 08 05:17 PM
BRIDGET A ROSS	Director	Aug 08 '25	Proposed Sale	94.00	2,500	235,000		Aug 08 04:22 PM
LeMaitre George W	Officer	Aug 06 '25	Proposed Sale	93.51	100,000	9,350,530		Aug 06 11:42 AM
LeMaitre George W	Chairman and CEO	May 20 '25	Option Exercise	44.64	34,619	1,545,293	1,831,402	May 20 07:11 PM
LeMaitre George W	Chairman and CEO	May 19 '25	Sale	85.79	76,868	6,594,334	1,796,783	May 20 07:11 PM
LeMaitre George W	Chairman and CEO	May 16 '25	Sale	84.77	18,733	1,587,923	1,873,651	May 20 07:11 PM
LeMaitre George W	Chairman and CEO	May 20 '25	Sale	85.10	4,399	374,374	1,827,003	May 20 07:11 PM
Ross Bridget A	Director	May 12 '25	Option Exercise	30.00	3,750	112,500	6,666	May 14 04:03 PM
Ross Bridget A	Director	May 12 '25	Sale	83.20	3,750	312,000	2,916	May 14 04:03 PM
Ross Bridget A	Director	May 12 '25	Proposed Sale	83.20	3,750	312,000		May 12 05:42 PM
Kamke Trent G	Senior V. P., Operations	Mar 14 '25	Option Exercise	36.92	2,709	100,006	3,753	Mar 14 04:53 PM
Kamke Trent G	Senior V. P., Operations	Mar 12 '25	Option Exercise	23.56	2,009	47,332	7,573	Mar 14 04:53 PM
Kamke Trent G	Senior V. P., Operations	Mar 13 '25	Sale	79.66	4,520	360,073	1,044	Mar 14 04:53 PM
Kamke Trent G	Senior V. P., Operations	Mar 12 '25	Sale	82.12	2,009	164,979	5,564	Mar 14 04:53 PM
TRENT G KAMKE	Officer	Mar 13 '25	Proposed Sale	79.66	4,520	360,074		Mar 13 04:26 PM
Kamke Trent G	Officer	Mar 12 '25	Proposed Sale	82.12	2,009	164,979		Mar 12 05:24 PM
Roberts David B	President and Director	Mar 07 '25	Option Exercise	35.48	2,818	99,983	17,976	Mar 11 04:34 PM
Jasinski Lawrence J	Director	Mar 04 '25	Sale	92.00	3,142	289,064	2,607	Mar 06 05:16 PM
LeMaitre George W	Officer	Mar 05 '25	Proposed Sale	89.46	200,000	17,892,000		Mar 05 12:46 PM
SHADAN MARTHA	Director	Feb 28 '25	Option Exercise	0.00	1	0	1,936	Mar 04 07:32 PM
Roush John A	Director	Feb 28 '25	Option Exercise	0.00	1	0	2,916	Mar 04 07:30 PM
Ross Bridget A	Director	Feb 28 '25	Option Exercise	0.00	1	0	2,916	Mar 04 07:25 PM
O'Connor John James	Director	Feb 28 '25	Option Exercise	0.00	1	0	57,301	Mar 04 07:23 PM
Jasinski Lawrence J	Director	Feb 28 '25	Option Exercise	0.00	1	0	5,749	Mar 04 07:20 PM
Kamke Trent G	Senior V. P., Operations	Feb 28 '25	Option Exercise	0.00	2	0	5,384	Mar 04 07:14 PM
Pellegrino Joseph P JR	Chief Financial Officer	Feb 28 '25	Option Exercise	0.00	5	0	9,769	Mar 04 07:10 PM
Roberts David B	President and Director	Feb 28 '25	Option Exercise	0.00	5	0	15,361	Mar 04 07:04 PM
LeMaitre George W	Chairman and CEO	Feb 28 '25	Option Exercise	0.00	11	0	1,892,831	Mar 04 06:53 PM
Jasinski Lawrence J	Director	Mar 04 '25	Proposed Sale	92.00	3,142	289,064		Mar 04 04:49 PM
LeMaitre George W	Chairman and CEO	Dec 20 '24	Option Exercise	0.00	53	0	1,891,792	Dec 26 04:14 PM
Roberts David B	President and Director	Dec 20 '24	Option Exercise	0.00	17	0	14,657	Dec 26 04:13 PM
Pellegrino Joseph P JR	Chief Financial Officer	Dec 20 '24	Option Exercise	0.00	17	0	9,248	Dec 26 04:12 PM
Kamke Trent G	Senior V. P., Operations	Dec 20 '24	Option Exercise	0.00	9	0	5,129	Dec 26 04:11 PM
Jasinski Lawrence J	Director	Dec 12 '24	Option Exercise	0.00	6	0	5,544	Dec 13 06:01 PM
Jasinski Lawrence J	Director	Dec 11 '24	Option Exercise	0.00	6	0	5,538	Dec 13 06:01 PM
Roberts David B	President and Director	Dec 12 '24	Option Exercise	0.00	22	0	15,034	Dec 13 06:00 PM
Roberts David B	President and Director	Dec 11 '24	Option Exercise	0.00	18	0	15,208	Dec 13 06:00 PM
Pellegrino Joseph P JR	Chief Financial Officer	Dec 12 '24	Option Exercise	0.00	22	0	9,827	Dec 13 05:59 PM
Pellegrino Joseph P JR	Chief Financial Officer	Dec 11 '24	Option Exercise	0.00	18	0	10,099	Dec 13 05:59 PM
O'Connor John James	Director	Dec 12 '24	Option Exercise	0.00	6	0	57,096	Dec 13 05:59 PM
O'Connor John James	Director	Dec 11 '24	Option Exercise	0.00	6	0	57,090	Dec 13 05:59 PM
Ross Bridget A	Director	Dec 12 '24	Option Exercise	0.00	6	0	2,711	Dec 13 05:57 PM
Ross Bridget A	Director	Dec 11 '24	Option Exercise	0.00	6	0	2,705	Dec 13 05:57 PM
Roush John A	Director	Dec 12 '24	Option Exercise	0.00	6	0	2,711	Dec 13 05:56 PM
Roush John A	Director	Dec 11 '24	Option Exercise	0.00	6	0	2,705	Dec 13 05:56 PM
LeMaitre George W	Chairman and CEO	Dec 12 '24	Option Exercise	0.00	52	0	1,893,055	Dec 13 05:56 PM
LeMaitre George W	Chairman and CEO	Dec 11 '24	Option Exercise	0.00	40	0	1,893,650	Dec 13 05:56 PM
SHADAN MARTHA	Director	Dec 12 '24	Option Exercise	0.00	6	0	1,731	Dec 13 05:54 PM
Kamke Trent G	Senior V. P., Operations	Dec 12 '24	Option Exercise	0.00	10	0	5,298	Dec 13 05:53 PM
Kamke Trent G	Senior V. P., Operations	Dec 11 '24	Option Exercise	0.00	7	0	5,376	Dec 13 05:53 PM
SHADAN MARTHA	Director	Dec 09 '24	Option Exercise	0.00	1	0	1,725	Dec 11 09:27 PM
Roush John A	Director	Dec 09 '24	Option Exercise	0.00	1	0	2,699	Dec 11 09:24 PM
Ross Bridget A	Director	Dec 09 '24	Option Exercise	0.00	1	0	2,699	Dec 11 09:22 PM
O'Connor John James	Director	Dec 09 '24	Option Exercise	0.00	1	0	57,084	Dec 11 09:21 PM
Jasinski Lawrence J	Director	Dec 09 '24	Option Exercise	0.00	1	0	5,532	Dec 11 09:17 PM
Kamke Trent G	Senior V. P., Operations	Dec 09 '24	Option Exercise	0.00	2	0	5,446	Dec 11 09:14 PM
Pellegrino Joseph P JR	Chief Financial Officer	Dec 09 '24	Option Exercise	0.00	4	0	10,336	Dec 11 09:11 PM
Roberts David B	President and Director	Dec 09 '24	Option Exercise	0.00	4	0	15,359	Dec 11 09:08 PM
LeMaitre George W	Chairman and CEO	Dec 09 '24	Option Exercise	0.00	9	0	1,894,142	Dec 11 09:04 PM
Kamke Trent G	Senior V. P., Operations	Dec 02 '24	Option Exercise	0.00	2	0	4,563	Dec 04 05:07 PM
Pellegrino Joseph P JR	Chief Financial Officer	Dec 02 '24	Option Exercise	0.00	12	0	8,821	Dec 04 05:04 PM
Roberts David B	President and Director	Dec 02 '24	Option Exercise	0.00	12	0	14,126	Dec 04 05:02 PM
LeMaitre George W	Chairman and CEO	Dec 02 '24	Option Exercise	0.00	32	0	1,889,486	Dec 04 04:59 PM
O'Connor John James	Director	Nov 25 '24	Option Exercise	35.48	7,500	266,100	56,663	Nov 27 05:16 PM
LeMaitre George W	Chairman and CEO	Nov 22 '24	Option Exercise	39.03	2,818	109,987	1,889,454	Nov 26 04:15 PM
Jasinski Lawrence J	Director	Nov 20 '24	Sale	103.50	198	20,493	5,111	Nov 22 04:22 PM
Ross Bridget A	Director	Nov 15 '24	Option Exercise	30.00	3,750	112,500	6,028	Nov 19 06:05 PM
Ross Bridget A	Director	Nov 15 '24	Sale	101.47	3,750	380,512	2,278	Nov 19 06:05 PM
Ross Bridget A	Director	Nov 15 '24	Proposed Sale	101.47	3,750	380,512		Nov 15 05:25 PM
SHADAN MARTHA	Director	Nov 13 '24	Option Exercise	47.19	1,070	50,493	2,770	Nov 15 05:01 PM
SHADAN MARTHA	Director	Nov 13 '24	Sale	103.37	1,466	151,547	1,304	Nov 15 05:01 PM
SHADAN MARTHA	Director	Nov 13 '24	Proposed Sale	103.37	1,466	151,548		Nov 13 06:29 PM
Roberts David B	President and Director	Aug 13 '24	Option Exercise	35.01	3,063	107,221	17,177	Aug 15 06:48 PM
Roberts David B	President and Director	Aug 13 '24	Sale	82.07	3,063	251,380	14,114	Aug 15 06:48 PM
Roberts David B	Officer	Aug 13 '24	Proposed Sale	82.07	3,063	251,387		Aug 13 06:13 PM

LFWD

Lifeward Ltd

LMAT

Lemaitre Vascular Inc

Upgrade your FINVIZ experience